Access to the most advanced treatments depends heavily on strong clinical trial programs. The Zangmeister Center is an active participant in a broad range of research studies in cooperation with pharmaceutical companies, The Gynecologic Oncology Group and The National Cancer Institute’s Cooperative Groups (including Southwest Oncology Group and the Eastern Cooperative Group), through the Columbus Community Clinical Oncology Program. Clinical trials give patients broader access to new treatment options and are essential to our mission of providing the most advanced care available to the patients we serve. In addition to providing promising alternatives to our patients today, these studies can dramatically improve the prognoses for generations of future oncology patients.


